Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00105937
Other study ID # 099-15
Secondary ID
Status Completed
Phase Phase 3
First received March 18, 2005
Last updated June 27, 2012
Start date April 2004
Est. completion date November 2006

Study information

Verified date May 2007
Source Teva Pharmaceutical Industries
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the long-term safety and efficacy of OraVescent fentanyl to treat breakthrough pain episodes in cancer patients who are already opioid tolerant.


Description:

The objective of this study is to determine the tolerability and safety of OraVescent fentanyl when used long term to relieve breakthrough pain in opioid tolerant cancer patients.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date November 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- 18-80 years of age

- Average of 1-4 breakthrough pain episodes per day

- Opioid tolerant

- Histologically documented diagnosis of a malignant solid tumor or hematological malignancy

Exclusion Criteria:

- Primary breakthrough pain is not related to cancer in any way

- Opioid or fentanyl intolerance

- Chronic obstructive pulmonary disease (COPD) or heart disease

- Sleep apnea or active brain metastases with increased cranial pressure

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
OraVescent fentanyl citrate


Locations

Country Name City State
United States Cancer Outreach Associates, PC Abingdon Virginia
United States Allegheny Pain Management, PC Altoona Pennsylvania
United States Southeastern Gynecologic Oncology, LLC Atlanta Georgia
United States St. Agnes Healthcare Baltimore Maryland
United States City of Hope National Medical Center Duarte California
United States Oncology Associates of Oregon Eugene Oregon
United States Kentucky Cancer Clinic Hazard Kentucky
United States Hot Spring Pain Clinic Hot Springs Arkansas
United States Saint Joseph's Mercy Cancer Center Hot Springs Arkansas
United States Center for Pain Management Huntsville Alabama
United States Florida Institute of Medical Research Jacksonville Florida
United States University of Florida Shands Cancer Center at Jacksonville Jacksonville Florida
United States Southwest Oncology Associates Lafayette Louisiana
United States Hematology Oncology Associates Lake Worth Florida
United States St. Mary Medical Center Langhorne Pennsylvania
United States University of Wisconsin Medical School Madison Wisconsin
United States North Shore University Hospital Manhasset New York
United States Innovative Medical Research of South Florida Miami Shores Florida
United States Hematology and Oncology Specialists New Orleans Louisiana
United States Beth Israel Medical Center New York New York
United States Mohamed Haq Pasadena Texas
United States Arkansas Cancer Institute Pine Bluff Arkansas
United States Huron Medical Center Port Huron Michigan
United States MedSource Inc Richmond Virginia
United States Bond Clinic, Inc Rolla Missouri
United States Hunstman Cancer Institute Salt Lake City Utah
United States Palliative Care and Pain Medicine Salt Lake City Utah
United States Cancer Care Centers of South Texas San Antonio Texas
United States North Shore Cancer Research Association Skokie Illinois
United States The Cancer Prevention and Treatment Center Soquel California
United States Providence Cancer Institute Southfield Michigan
United States HealthCare Research, LLC St. Louis Missouri
United States Gulf Coast Oncology Association St. Petersburg Florida
United States Clinical Pharmacology Services, Inc Tampa Florida
United States Northwestern Connecticut Oncology & Hematology Associates Torrington Connecticut
United States Arizona Clinical Research Center Tucson Arizona
United States Outcomes Research International Tucson Arizona
United States PETC Research Group, Inc. Tulsa Oklahoma
United States UTHCT (ATTN: Clinical Research) Tyler Texas
United States Palm Beach Research West Palm Beach Florida
United States Great Basin Clinical Research West Point Utah
United States The Center for Clinical Research, LLC Winston-Salem North Carolina
United States Florida Medical Clinic, PA Zephyrhills Florida

Sponsors (1)

Lead Sponsor Collaborator
Cephalon

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Tolerability and safety of OraVescent fentanyl when used long-term
Secondary Assess the effectiveness of OraVescent fentanyl
Secondary Assess the development of incremental tolerance
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care